Leonard Sank - Net Worth and Insider Trading

Leonard Sank Net Worth

The estimated net worth of Leonard Sank is at least $1 Million dollars as of 2024-05-20. Leonard Sank is the Director of Oramed Pharmaceuticals Inc and owns about 592,013 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $1 Million. Details can be seen in Leonard Sank's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Leonard Sank has not made any transactions after 2019-09-09 and currently still holds the listed stock(s).

Transaction Summary of Leonard Sank

To

Leonard Sank Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leonard Sank owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .

Click here to see the complete history of Leonard Sank’s form 4 insider trades.

Insider Ownership Summary of Leonard Sank

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2019-09-09 director

Leonard Sank Latest Holdings Summary

Leonard Sank currently owns a total of 1 stock. Leonard Sank owns 592,013 shares of Oramed Pharmaceuticals Inc (ORMP) as of September 9, 2019, with a value of $1 Million.

Latest Holdings of Leonard Sank

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORMP Oramed Pharmaceuticals Inc 2019-09-09 592,013 2.30 1,361,630

Holding Weightings of Leonard Sank


Leonard Sank Form 4 Trading Tracker

According to the SEC Form 4 filings, Leonard Sank has made a total of 3 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 25,000 shares on September 9, 2019, which cost Leonard Sank around $73,000.

Insider Trading History of Leonard Sank

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Leonard Sank Trading Performance

GuruFocus tracks the stock performance after each of Leonard Sank's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leonard Sank is 15.93%. GuruFocus also compares Leonard Sank's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leonard Sank within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Leonard Sank's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Leonard Sank

Average Return

Average return per transaction

Outperforming Transactions

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.41
Relative Return to S&P 500(%) 1.34

Leonard Sank Ownership Network

Ownership Network List of Leonard Sank

No Data

Ownership Network Relation of Leonard Sank


Leonard Sank Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

Leonard Sank is the director of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

Over the past 18 months, Leonard Sank made no insider transaction in Oramed Pharmaceuticals Inc (ORMP). Other recent insider transactions involving Oramed Pharmaceuticals Inc (ORMP) include a net purchase of 126,000 shares made by Nadav Kidron , a net sale of 100,000 shares made by Miriam Kidron , and a net purchase of 70,000 shares made by Yadin Rozov .

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 113,325 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 196,000 shares were bought by its insiders, resulting in a net purchase of 82,675 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

Leonard Sank Mailing Address

Above is the net worth, insider trading, and ownership report for Leonard Sank. You might contact Leonard Sank via mailing address: 3 Blair Road, Cape Town T3 8005.

Discussions on Leonard Sank

No discussions yet.